DRTCX
Price
$21.23
Change
-$0.19 (-0.89%)
Updated
Jul 13 closing price
Net Assets
518.69M
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

DRTCX vs VFFSX

DRTCX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
DRTCX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTCX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. DRTCX (519M). VFFSX pays higher dividends than DRTCX: VFFSX (1.08) vs DRTCX (0.19). DRTCX was incepted earlier than VFFSX: DRTCX (27 years) vs VFFSX (10 years). DRTCX (0.70) is less costly to investors than VFFSX (0.01). DRTCX is a more actively managed with annual turnover of: 27.23 vs. VFFSX (2.00). DRTCX has a lower initial minimum investment than VFFSX: DRTCX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. DRTCX (6.37). VFFSX return over 5 years is better than : 73.48 vs. DRTCX (14.25).
DRTCXVFFSXDRTCX / VFFSX
Total Expense Ratio0.700.017,000%
Annual Report Gross Expense Ratio0.700.017,000%
Fund Existence27 years10 years-
Gain YTD8.23610.68577%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets519M1.67T0%
Annual Yield % from dividends0.191.0818%
Returns for 1 year6.3721.0730%
Returns for 3 years36.4668.4553%
Returns for 5 years14.2573.4819%
Returns for 10 years76.00251.2130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6